This Article
-
J Nucl Med December 1, 2005 vol. 46 no. 12 1940-1945
- Show PDF in full window
- Figures Only
- Full Text
- » Full Text (PDF)
Classifications
Services
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
-
CiteULike
Delicious
Digg
Facebook
Google+
LinkedIn
Mendeley
Reddit
Twitter
Current Issue
This Month in JNM
- FEATURED ARTICLE OF THE MONTH: 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi
- FEATURED CLINICAL INVESTIGATION ARTICLE: Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)
- THE STATE OF THE ART: Forward to the Past: The Case for Quantitative PET Imaging
- HOT TOPICS: The Future of Radioligand Therapy: α, β, or Both?
- FOCUS ON MOLECULAR IMAGING: Molecular Imaging of PARP
- ACR and SNMMI Joint Credentialing Statement for PET/MRI of the Body
- Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients
- Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1–Deficient Mice
Most
-
Viewed
- 68Ga or 18F for Prostate Cancer Imaging?
- Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
- Machine Learning Will Change Medicine
- Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging Is Misguided and Detrimental
- PET Imaging for Endocrine Malignancies: From Woe to Go
-
Cited
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
- 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur of Non-Trivial Proportion
- PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
